Interestingly, one study also described decreased OPA1, MFN2, DRP1, and PARKIN levels in DM1-derived fibroblasts, pointing toward ineffective mitophagic mechanisms [4]. The gene discussed is PRKN; the disease is myotonic dystrophy type 1.